key: cord-0743252-5c1y4urq
authors: Venkateswaran, Kotamma; Aw, Derrick Chen‐Wee; Huang, Jingxiang; Angkodjojo, Stanley
title: Dermatomyositis following COVID‐19 vaccination
date: 2022-04-07
journal: Dermatol Ther
DOI: 10.1111/dth.15479
sha: 6303837541ee186708baa07fe69f7058eefe06f8
doc_id: 743252
cord_uid: 5c1y4urq

nan

Infections and vaccines can occasionally cause new-onset or flare of autoimmune-mediated diseases. 7,8 COVID-19 infections were found to increase autoantibodies targeting a wide variety of tissues. 9 

Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registrybased study of 414 cases

Clinical and histopathological spectrum of delayed adverse cutaneous reactions following COVID-19 vaccination

Clinical and pathologic correlation of cutaneous COVID-19 vaccine reactions including V-REPP: a registry-based study

The histologic and molecular correlates of COVID-19 vaccine-induced changes in the skin

Subacute cutaneous lupus erythematosus flare triggered by COVID-19 vaccine

Induction and exacerbation of subacute cutaneous lupus erythematosus following mRNA-based or adenoviral vector-based SARS-CoV-2 vaccination

Vaccines, adjuvants and autoimmunity

Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA/DNA SARS-CoV-2 vaccination. Vaccines (Basel)

Diverse functional autoantibodies in patients with COVID-19